21.

CONCENTRATIONS

Major Customers

For the years ended December 31, 2015, 2014 and 2013, approximately 37%, 6% and 24% of the Company’s total revenues were received from two customers for continued operation. For the years ended December 31, 2015, 2014 and 2013, approximately 7%, 11% and 11% of the Company’s total revenues were received from two customers for discontinued operation.

Major Suppliers

For the years ended December 31, 2015, 2014 and 2013, purchases from three suppliers for continued operation were approximately 67%, 28% and 42% of the total purchase, respectively. For the years ended December 31, 2015, 2014 and 2013, purchases from three suppliers for discontinued operation were approximately 9%, 55% and 51% of the total purchase, respectively.

Revenues

For the years ended December 31, 2015, 2014 and 2013, the Company’s top three selling products accounted, in the aggregate, for approximately 72%, 74% and 67%, respectively, of its total net revenues.

The following represents the revenues by product line, all derived from China:

	For the years ended
	December 31,
	2015		2014		2013
	US$		US$		US$
Products Line

Medical Devices		1,500,957		16,000,881		14,824,028
Respiratory and Oxygen Homecare		20,573		53,755		2,034,150
Mobile Medicine		164,503		1,631,413		-
Total Revenues		1,686,033		17,686,049		16,858,178
Less: revenues from discontinued operations		(364,490)		(14,911,808)		(9,455,705)
Revenues from continuing operations		1,321,543		2,774,241		7,402,473